Aberdeen Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Aberdeen Asset Management's LLY Position: Q2 2017 in Review
Aberdeen Asset Management increased its Eli Lilly (LLY) stake by 14% in Q2 2017, buying an estimated $2.66M and bringing the position to 268,608 shares worth $22.1M. The position accounts for 0.07% of the portfolio, ranked #235.
Aberdeen Asset Management first reported a position in LLY in Q2 2013 and has held it in 17 quarters since. The position peaked at $43.8M in Q2 2014. 1,247 funds tracked by Wall St. Rank hold LLY as of Q2 2017.
- Aberdeen Asset Management held 268,608 shares of Eli Lilly worth $22.1M as of Q2 2017.
- Aberdeen Asset Management bought 32,576 Eli Lilly shares in Q2 2017, an estimated $2.66M.
- Eli Lilly made up 0.07% of Aberdeen Asset Management's portfolio in Q2 2017, its #235 holding.
- Aberdeen Asset Management first reported a position in Eli Lilly in Q2 2013 and has held it in 17 quarters since.
- Aberdeen Asset Management's Eli Lilly position peaked at $43.8M in Q2 2014.
- 1,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2017.
Based on Aberdeen Asset Management's 13F filing for Q2 2017, filed 10 Aug 2017.